机构:[1]Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[2]West China School of Medicine, Sichuan University, Chengdu, China四川大学华西医院[3]Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China
This study was supported by grants from the National Natural Science Foundation of China (82070784, 81702536) to J. A., a grant from Science & Technology Department of Sichuan Province, China (2022JDRC0040) to J. A, a grant from Science & Technology Department of Sichuan Province, China (2020YJ0054, 2021YFC2009304) to L. L, a grant from Beijing National Laboratory for Molecular Sciences (BNLMS202108) to X.W., and the Chinese Academy of Sciences Pioneer Hundred Talents Program
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|2 区生物学
小类|2 区生化与分子生物学3 区细胞生物学
最新[2023]版:
大类|2 区生物学
小类|2 区生化与分子生物学3 区细胞生物学
第一作者:
第一作者机构:[1]Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, China[2]West China School of Medicine, Sichuan University, Chengdu, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Li Jin,Yi Xianyanling,Liu Liangren,et al.Advances in tumor nanotechnology: theragnostic implications in tumors via targeting regulated cell death[J].Apoptosis : an international journal on programmed cell death.2023,doi:10.1007/s10495-023-01851-3.
APA:
Li Jin,Yi Xianyanling,Liu Liangren,Wang Xiaohui&Ai Jianzhong.(2023).Advances in tumor nanotechnology: theragnostic implications in tumors via targeting regulated cell death.Apoptosis : an international journal on programmed cell death,,
MLA:
Li Jin,et al."Advances in tumor nanotechnology: theragnostic implications in tumors via targeting regulated cell death".Apoptosis : an international journal on programmed cell death .(2023)